CLn Skin Care Appoints Ken Curley as Chief Commercial Officer
Experienced Dermatology Industry Leader to Guide Commercial Expansion While Preserving CLn's Physician-Founded Mission DALLAS, TEXAS / ACCESS Newswire / January...
Pharmaceutical
Jaguar Health Presenting January 15 at Lytham Partners Healthcare Investor Summit to Provide Updates on Near-Term Catalysts
SAN FRANCISCO, CA / ACCESS Newswire / January 14, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte,...
Jaguar Health Presenting January 15 at Lytham Partners Healthcare Investor Summit to Provide Updates on Near-Term Catalysts
SAN FRANCISCO, CA / ACCESS Newswire / January 14, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte,...
Who Are the 50 Most Influential People in Pharmacy for 2025?
The Pharmacy Podcast Network (PPN) will stage the "Pharmacy 50 Awards" LIVE Stream on Friday, January 16, 2026, at 2:00...
Who Are the 50 Most Influential People in Pharmacy for 2025?
The Pharmacy Podcast Network (PPN) will stage the "Pharmacy 50 Awards" LIVE Stream on Friday, January 16, 2026, at 2:00...
Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026)
- Presentation to Include Additional Positive Data from the Recently Completed PRIME Clinical Study - SAN DIEGO, CA / ACCESS...
Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026)
- Presentation to Include Additional Positive Data from the Recently Completed PRIME Clinical Study - SAN DIEGO, CA / ACCESS...
Genomate Health Expands Global Footprint With Acquisition of Oncompass Medicine
Genomate Health, the U.S.-based precision medicine company transforming cancer care through its proprietary computational reasoning technology, today announced its acquisition...
Genomate Health Expands Global Footprint With Acquisition of Oncompass Medicine
Genomate Health, the U.S.-based precision medicine company transforming cancer care through its proprietary computational reasoning technology, today announced its acquisition...
GridAI and the New Operating Reality of the Electric Grid
BOCA RATON, FL / ACCESS Newswire / January 14, 2026 / For decades, managing the electric grid was largely a...
GridAI and the New Operating Reality of the Electric Grid
BOCA RATON, FL / ACCESS Newswire / January 14, 2026 / For decades, managing the electric grid was largely a...
Dr. Kirk Lozada’s Insights on Why Rhinoplasty Should Never Depend on a Single Technique
Philadelphia-based facial plastic surgeon discusses the importance of surgical adaptability and anatomical assessment in modern rhinoplasty. PHILADELPHIA, PA / ACCESS...
Dr. Kirk Lozada’s Insights on Why Rhinoplasty Should Never Depend on a Single Technique
Philadelphia-based facial plastic surgeon discusses the importance of surgical adaptability and anatomical assessment in modern rhinoplasty. PHILADELPHIA, PA / ACCESS...
Aspire Biopharma Announces Reverse Stock Split
ESTERO, FL / ACCESS Newswire / January 14, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a...
Black Book’s 2026 Physician Practice Management Solutions Report Quantifies Platform-Level Operational Performance Signals Across Ambulatory Care
Validated national polling finds support execution, prior-authorization friction, production-grade interoperability, and AI governance are shaping the next phase of practice...
Zomedica Announces “Fourth Friday at Four” Webinar on January 23rd Focused on Digital Innovation & Technology-Driven Growth
January session to highlight Zomedica's expanding digital capabilities and long-term innovation strategy ANN ARBOR, MI / ACCESS Newswire / January...
Orion updates time estimate for the potential related to the annual Nubeqa® net sales recorded by Orion
ORION CORPORATION STOCK EXCHANGE RELEASE 14 JANUARY 2026 at 16:00 EET Orion updates time estimate for the potential related to the...
Clearmind Medicine Announces Successful Completion of Treatment in All Patients of the Second Cohort in Ongoing Phase I/IIa Clinical Trial for CMND-100
Vancouver, Canada, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a...
SL BIO Ltd. and Horizon Space Acquisition II Corp. Announce Registration Statement Effectiveness and Extraordinary General Meeting Date to Approve Business Combination
TAIPEI, Taiwan & NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- SL BIO Ltd. ("SL Bio" or the “Company”), a...
SELLAS Life Sciences Enters Agreement with IMPACT-AML to Expand SLS009 Clinical Program into Europe
Supports capital-efficient expansion of the SLS009 clinical program into frontline AML, enabling broader U.S. and European patient enrollment U.S. enrollment evaluating...